The PGIMER examiner is
Prof. Davinder Parsad. “Devender/Devinder Prasad” is a commonly used spelling variant in older reports, but PGIMER’s official profile lists him as
Prof. Davinder Parsad, Professor, Department of Dermatology, Venereology and Leprology. His stated interests are
vitiligo pathogenesis and clinical research, pigmentary disorders, and urticaria. His funded work also includes melanocyte-keratinocyte models, melanocyte biology, pigmentation, and vitiligo-related molecular mechanisms. See the
official PGIMER profile.
Prof.
Ghanshyam K. Verma is confirmed as Professor and Head at IGMC Shimla. His publication pattern is strongest in
contact dermatitis and patch testing, photodermatitis, cutaneous infections and tropical dermatology, leprosy, STIs, and local epidemiology. The
IGMC faculty listing confirms the appointment.
This is probably his most consistent clinical-academic theme.
-
Trends of common contact sensitizers in tandem with increased hair dye dermatitis in Shimla: a study of 521 patients
- Focus: hair-dye dermatitis, PPD, Parthenium, nickel, dichromate, patch testing.
- The article’s keywords and cohort design show a strong department-level interest in contact allergen patterns in the sub-Himalayan region. Read the full article page.
-
Pesticide contact dermatitis in fruit and vegetable farmers of Himachal Pradesh
- G. Verma et al. Contact Dermatitis, 2007.
- Focus: occupational dermatitis, agricultural exposure, relevant history, prevention, and patch testing.
- Practical relevance: a farmer with hand/face dermatitis should trigger questions on pesticides, rubber gloves, plants, sunlight, and airborne contact dermatitis.
-
Purpuric contact dermatitis from footwear
- G. K. Verma et al. Contact Dermatitis, 2007. PubMed
- Focus: atypical morphology of footwear dermatitis and its distinction from vasculitis or purpura.
- Learn: common footwear allergens, distribution by shoe component, patch testing with standard and patient’s own materials.
-
Amoebiasis cutis: clinical suspicion is the key to early diagnosis
- Verma GK et al. Australasian Journal of Dermatology, 2010. PubMed
- Read for an approach to chronic destructive ulcers, especially perianal/perineal/gluteal lesions.
- Must know: fresh wet mount from ulcer margin can demonstrate Entamoeba histolytica trophozoites; histology can show trophozoites.
-
A case of extensive chromoblastomycosis from North India
- Verma GK et al. Brazilian Journal of Microbiology, 2014. PubMed and free full text
- Must know:
- Clinical morphology: chronic verrucous/nodular plaques, often on lower limb.
- Histology/KOH: muriform bodies, also called sclerotic or Medlar bodies.
- Culture in the case: Fonsecaea pedrosoi.
- Differentiate from tuberculosis verrucosa cutis, verrucous carcinoma, chromoblastomycosis, mycetoma, and cutaneous leishmaniasis.
-
Nocardial mycetoma: diverse clinical presentations
- Sharma NL et al., including G. K. Verma. IJDVL, 2008. Journal article
- Revise:
- Triad: tumefaction, sinuses, grains.
- Eumycetoma versus actinomycetoma.
- Grain color, microscopy, culture, imaging, and broad treatment principles.
-
Cutaneous leishmaniasis and Himachal Pradesh
- His collaborative work includes vector and epidemiology studies in Himachal Pradesh, including sandflies in the Satluj valley and atypical cutaneous manifestations of Leishmania donovani.
- Practical preparation: revise cutaneous leishmaniasis morphology, slit-skin smear and histology, differential from lupus vulgaris/chromoblastomycosis, and the relevance of geographic history.
His research projects strongly support a focus on melanocyte biology, vitiligo pathogenesis, repigmentation, cellular models, melanin/melanosome biology, and vitiligo surgery. This is the examiner for whom you should be able to manage a vitiligo case fluently from diagnosis to surgery.
-
Standard guidelines of care for vitiligo surgery
- Parsad D, Gupta S. IJDVL, 2008. PubMed
- This is your single most important article.
- Learn:
- Surgery is for stable, treatment-resistant vitiligo.
- Practical criterion: no new lesions or extension for around one year, with a test graft in doubtful cases.
- Preoperative evaluation, counseling, consent, anesthetic issues, postoperative immobilization, and complications.
- Why disease stability matters more than extent alone.
-
Vitiligo surgery: its evolution as a definite treatment in stable vitiligo
- Holla AP, Parsad D. Giornale Italiano di Dermatologia e Venereologia, 2010. PubMed
- Read this to compare tissue grafts and cellular grafts.
-
Vitiligo surgery: a journey from tissues via cells to the stems!
- Razmi T, Afra TP, Parsad D. Experimental Dermatology, 2019. PubMed
- Useful overview of the evolution from conventional grafting to cell suspension and regenerative approaches.
-
Four-compartment method: simplified and cost-effective non-cultured epidermal cell suspension
- Kumar R, Parsad D, Singh C, Yadav S. British Journal of Dermatology, 2014. PubMed
- Key message: non-cultured epidermal cell suspension transplantation can be simplified and performed with less reliance on expensive laboratory equipment.
- Learn the principle of donor-to-recipient expansion ratio and why cellular grafting is useful for larger areas.
-
Non-cultured epidermal cell suspension transplantation in children and adolescents with stable vitiligo
- Sahni K, Parsad D, Kanwar AJ. Clinical and Experimental Dermatology, 2011. PubMed
- Important if a pediatric vitiligo case appears.
-
Acral vitiligo and lesions over joints treated with non-cultured epidermal cell suspension transplantation
- Holla AP et al., including Parsad D. Clinical and Experimental Dermatology, 2013. PubMed
- Revise why acral sites and joints are treatment-resistant and how expectations should be counseled.
-
Comparison of systemic PUVA and NB-UVB in vitiligo
- Bhatnagar A, Kanwar AJ, Parsad D, De D. JEADV, 2007. PubMed
- Randomized prospective study.
- Key conclusion: NB-UVB gave better repigmentation after excluding therapy-resistant acral sites.
- Viva point: NB-UVB is generally preferred to oral PUVA in modern routine care due to practicality and safety considerations.
-
PUVA and NB-UVB in inducing stability, assessed by VIDA
- Bhatnagar A et al., including Parsad D. JEADV, 2007. PubMed
- Know the Vitiligo Disease Activity score, VIDA:
- +4: activity in past 6 weeks
- +3: activity in past 3 months
- +2: activity in past 6 months
- +1: activity in past year
- 0: stable for at least 1 year
- -1: stable with spontaneous repigmentation for at least 1 year
-
Topical tacrolimus for childhood vitiligo in Asians
- Kanwar AJ, Dogra S, Parsad D. Clinical and Experimental Dermatology, 2004. PubMed
- Revise topical calcineurin inhibitors, especially for facial/intertriginous sites and children.
-
Effectiveness of oral Ginkgo biloba in limited, slowly spreading vitiligo
-
Vitiligo in full depth
- Classification, active versus stable disease, VIDA, Wood lamp examination.
- Medical therapy and NB-UVB.
- Surgical indications, procedures, complications, counseling.
- Vitiligo differentials.
-
Contact dermatitis and photodermatitis
- Standard patch testing.
- Photopatch test.
- PPD/hair dye, Parthenium, footwear, occupational dermatitis.
- Phototoxic versus photoallergic dermatitis.
-
Leprosy and infections
- Leprosy examination, reactions, MDT and disability.
- Chromoblastomycosis, mycetoma, sporotrichosis, cutaneous leishmaniasis, cutaneous amoebiasis.
- KOH, slit-skin smear, fungal culture, biopsy findings.
-
Syphilis
- Classic clinical morphology, tests, staging, treatment framework, follow-up.
The papers above show the examiners’ interests, but older individual studies should not replace present guideline-based care. In particular, treatments such as Ginkgo, calcipotriol combinations, and stanozolol should be described as historical or limited-evidence adjuncts. Recent systematic reviews on vitiligo therapies continue to evaluate regenerative and systemic approaches, but do not overturn the core practical framework of disease activity assessment, topical therapy, phototherapy, and properly selected surgery. Relevant recent reviews include
PMID 39509558 and
PMID 38454597.